HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.2
  1. Home
  2. /Reaction

Diisopropylethylamine → (S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amide

HRID 19019
Print

Reaction equation

HRID 19019 reaction equation
[CH2:1]([O:3][C:4]1[CH:24]=[CH:23][CH:22]=[CH:21][C:5]=1[O:6][C:7]1[CH2:11][N:10]([C@@H:12]([CH2:16][CH:17]([CH3:19])[CH3:18])[C:13]([OH:15])=O)[C:9](=[O:20])[CH:8]=1)[CH3:2].Cl.[OH:26][C@@H:27]([CH2:57]O)[CH2:28][N:29]1[CH:33]=[CH:32][C:31]([NH:34]C(=O)[C@@H](N2CC(OC3C=CC=C(Cl)C=3Cl)=CC2=O)CC(C)C)=[N:30]1.F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)N(C)C)C2C=CC=C[C:69]=2N=N1.C(N(CC)C(C)C)(C)C>CN(C)C=O.C(OCC)(=O)C>[OH:26][C:27]([CH3:57])([CH3:69])[CH2:28][N:29]1[CH:33]=[CH:32][C:31]([NH:34][C:13](=[O:15])[C@@H:12]([N:10]2[CH2:11][C:7]([O:6][C:5]3[CH:21]=[CH:22][CH:23]=[CH:24][C:4]=3[O:3][CH2:1][CH3:2])=[CH:8][C:9]2=[O:20])[CH2:16][CH:17]([CH3:19])[CH3:18])=[N:30]1
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

7

Reactant 4

HCID 81531DiisopropylethylamineHCID 151348Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphateHCID 66894832(S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acidHCID 66899094HMS5552 HCl

Product 1

HCID 57920168
(S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amide

Reagents, catalysts & solvents 2

HCID 6228DimethylformamideSolventHCID 8857Ethyl AcetateSolvent

Conditions

Temperature
25 °C

Procedure

A solution of (S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid (130 mg, 0.4 mmol) in N,N-dimethylformamide (4 mL) was treated with 1-(3-amino-pyrazol-1-yl)-2-methyl-propan-2-ol (prepared in U.S. Pat. Appl. US2008021032 Example 80, 75 mg, 0.46 mmol), benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (353 mg, 0.8 mmol) and N,N-diisopropylethylamine (103 mg, 0.8 mmol). The reaction mixture was stirred for 4 h at 25° C., under nitrogen. The reaction mixture was diluted with ethyl acetate, washed with saturated ammonium chloride, water, a saturated sodium chloride solution and dried over sodium sulfate. The organic layer was concentrated, and the crude product was purified by ISCO flash chromatography (Teledyne Isco RediSep Flash Column 12 g, 30% to 100% ethyl acetate/hexanes) to afford (S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amide as a fluffy material. This material was dissolved in diethyl ether (4 mL) and treated with hydrogen chloride in diethyl ether (1 M, 4 mL). Solvents were evaporated and the residue was triturated with diethyl ether. The solid was filtered to give (S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amide hydrochloride (45 mg, 23%): HR-ES-MS m/z calculated for C25H34N4O5 [M+H]+ 471.2602, observed 471.2603; 1H NMR (300 MHz, DMSO-d6) δ ppm 0.89 (d, J=6.6 Hz, 3H), 0.92 (d, J=6.6 Hz, 3H), 1.04 (br. s., 3H), 1.06 (br. s., 3H), 1.26 (t, J=6.8 Hz, 3H), 1.32-1.64 (m, 2H), 1.64-1.82 (m, 1H), 3.89 (s, 2H), 4.00-4.13 (m, 3H), 4.35-4.62 (m, 2H), 4.74 (s, 1H), 4.89 (dd, J=10.9, 4.5 Hz, 1H), 6.43 (d, J=2.1 Hz, 1H), 6.99 (t, J=6.9 Hz, 1H), 7.15-7.22 (m, 1H), 7.22-7.32 (m, 2H), 7.53 (d, J=2.1 Hz, 1H), 10.77 (s, 1H).

Workup

  1. washwashed with saturated ammonium chloride, water
  2. dry with materiala saturated sodium chloride solution and dried over sodium sulfate
  3. concentrationThe organic layer was concentrated
  4. customthe crude product was purified by ISCO flash chromatography (Teledyne Isco RediSep Flash Column 12 g, 30% to 100% ethyl acetate/hexanes)

Sources & evidence

ORD record
ord-3ff13002eefc4cf0b0deb0c0ac6fad2d
Source dataset
uspto-grants-2010_06
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07741327B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes